The US Food and Drug Administration (FDA) has approved an updated label for the controversial Alzheimer’s drug aducanumab (Aduhelm), emphasizing […]
Promising approach to treating Alzheimer’s disease developed
Researchers at the University of Gottingen and the Fraunhofer Institute for Cell Therapy and Immunology Leipzig-Halle have described a promising […]